(Q39067329)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28052625%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

title

Challenges in warranting access to prophylaxis and therapy for hepatitis B virus infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28052625%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28052625%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Markus Cornberg

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28052625%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

3

Michael P Manns

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28052625%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

language of work or name

1 reference

1 January 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28052625%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28052625%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

volume

37 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28052625%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

page(s)

67-72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28052625%20AND%20SRC:MED&resulttype=core&format=json

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

5 April 2020

cites work

1 reference

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

21 January 2018

1 reference

Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.

21 January 2018

1 reference

Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity

21 January 2018

1 reference

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

21 January 2018

1 reference

A comprehensive programme to reduce the incidence of hepatitis B virus infection and its sequelae in Alaskan natives

21 January 2018

1 reference

Time trends of chronic HBV infection over prior decades - A global analysis

21 January 2018

1 reference

Natural history of hepatitis B.

21 January 2018

1 reference

Hepatitis B virus infection--natural history and clinical consequences

21 January 2018

1 reference

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

21 January 2018

1 reference

AASLD guidelines for treatment of chronic hepatitis B.

21 January 2018

1 reference

Management of HBV and HBV/HDV-Associated Liver Cirrhosis

21 January 2018

1 reference

HBsAg seroclearance with NUCs: rare but important.

21 January 2018

1 reference

Review article: long-term safety of nucleoside and nucleotide analogues in HBV-monoinfected patients.

21 January 2018

1 reference

Low treatment rates in patients meeting guideline criteria in diverse practice settings

21 January 2018

1 reference

Requirements for global elimination of hepatitis B: a modelling study

21 January 2018

1 reference

Treatment for hepatitis B.

21 January 2018

1 reference

Hepatitis B prevention, diagnosis, treatment and care: a review

21 January 2018

1 reference

The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions

21 January 2018

1 reference

Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study

21 January 2018

1 reference

Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis

21 January 2018

1 reference

Chronic hepatitis B monitoring and treatment patterns in five European countries with different access and reimbursement policies

21 January 2018

1 reference

Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference

21 January 2018

1 reference

Limited access to hepatitis B/C treatment among vulnerable risk populations: an expert survey in six European countries

21 January 2018

1 reference

Current seroprevalence, vaccination and predictive value of liver enzymes for hepatitis B among refugees in Germany

21 January 2018

1 reference

Long-term follow-up and suboptimal treatment rates of treatment-eligible chronic hepatitis B patients in diverse practice settings: a gap in linkage to care

21 January 2018

1 reference

Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenarios

21 January 2018

1 reference

Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders

21 January 2018

1 reference

Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems

21 January 2018

1 reference

Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load

21 January 2018

1 reference

Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis

21 January 2018

1 reference

Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study

21 January 2018

1 reference

Screening for viral hepatitis prior to rituximab chemotherapy

21 January 2018

1 reference

Gastroenterologists Have Suboptimal Hepatitis B Virus Screening Rates in Patients Receiving Immunosuppressive Therapy.

21 January 2018

1 reference

Hepatitis B reactivation during cancer chemotherapy: an international survey of the membership of the American Association for the Study of Liver Diseases

21 January 2018

1 reference

Aktualisierung der S 3-Leitlinie zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/LIV.13320

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28052625%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

1 reference